CVE-2026-2035366

keystone: keystone: Application credential tokens can escape project scope via token-method reauthentication

Published n/a CVSS 3.1 · 7.1 High EPSS n/a KEV · Not listed
Description
A flaw was found in OpenStack Keystone where an application credential token can escape its intended project scope through token-method reauthentication. Keystone rejects an explicit scope change for an application credential token, but an omitted scope falls through to the owner's default project. If the owner has roles on that default project, Keystone issues a new token scoped there while still carrying the original application credential identity. Custom Keystone authentication plugins are subject to the same incomplete rescope guard. This allows a limited-scope application credential for one project to access another project within the owner's role assignments.

Remediation

No solution or workaround provided in the CVE record

Tracking

Sign in to view the affected projects.

Advisories

No advisories available
History
Type Values Removed Values Added
Description A flaw was found in OpenStack Keystone where an application credential token can escape its intended project scope through token-method reauthentication. Keystone rejects an explicit scope change for an application credential token, but an omitted scope falls through to the owner's default project. If the owner has roles on that default project, Keystone issues a new token scoped there while still carrying the original application credential identity. Custom Keystone authentication plugins are subject to the same incomplete rescope guard. This allows a limited-scope application credential for one project to access another project within the owner's role assignments.
Title keystone: keystone: Application credential tokens can escape project scope via token-method reauthentication
Weaknesses CWE-863
References
Metrics threat_severity

None

cvssV3_1

{'score': 7.1, 'vector': 'CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:L/A:N'}

threat_severity

Important

Subscriptions

No data.

Weaknesses

Sources